Dosimetric study of 103Pd Brachytherapy source (Theragenics, model 200) in water phantom and different tissues with GATE Monte Carlo code

Authors

Abstract

Brachytherapy is one of the most effective methods in the treatment of local malignant tumors. In this study, dosimetric parameters of 103Pd brachytherapy source Theragenics model 200 was estimated according to TG-43U1 protocol using GATE 8.1 Monte Carlo code. At first, validation of the GATE simulation for the seed was performed by some criteria consist of radial dose function and 2D anisotropy function inside liquid water according to the AAPM TG-43U1 recommendations. The maximum average deviations were found to be about 9% and 8% for radial dose function and anisotropy function, respectively. On the other hand, since the attenuation coefficient of the sources in the water phantom is different from that of various tissues, the effects of the various tissues on the radial dose function parameter of the 103Pd brachytherapy source were investigated using GATE 8.1 code. The relative deviation values of the radial dose function in the adipose, muscle, breast, and brain tissue compared with water phantom in the radial distance of 5cm were about 153%, 30%, 35%, and 29%, respectively. There is a good agreement between the results of this work and other study in calculation of dosimetric parameters of brachytherapy 103Pd source base on the recommendations of TG-43U1 protocol. The results show that the dosimetric parameters of 103Pd brachytherapy source can be accurately calculated using the GATE code in spite of low energy of radiation and high variation in dose rate with increasing distance from the center of the source. On the other hand, the results of the dose calculation in different phantom could be used in the clinical treatment planning systems.

Keywords


[1] P. Taherparvar, Z. Fardi. Development of GATE Monte Carlo Code for Simulation and Dosimetry of New I-125 Seeds in Eye Plaque Brachytherapy, Nuclear Medicine and Molecular Imaging, 55 (2021) 86-95. [2] R. Rajabi, P. Taherparvar. Monte Carlo dosimetry for a new 32P brachytherapy source using FLUKA code, Journal of contemporary brachytherapy, 11(1) (2019) 76-90. [3] Z. Fardi, P. Taherparvar. A Monte Carlo investigation of the dose distribution for new I-125 Low Dose Rate brachytherapy source in water and in different media, Polish Journal of Medical Physics and Engineering, 25(1) (2019) 15-22. [4] A. Moulavi, A. Binesh, H. Moslehitabar. Dose distribution and dosimetry parameters calculation of MED3633 palladium-103 source in water phantom using MCNP,4(1) (2006) 15-20. [5] B. Reniers, F. Verhaegen, S. Vynckier, The radial dose function of low-energy brachytherapy seeds in different solid phantoms: comparison between calculations with the EGSnrc and MCNP4C Monte Carlo codes and measurements, Physics in Medicine & Biology, 49(8) (2004) 1569-82. [6] M.J. Rivard, B.M. Coursey, L.A. DeWerd, W.F. Hanson, M. Saiful Huq, G.S. Ibbott, M.G. Mitch, R. Nath, J.F. Williamson. Update of AAPM Task Group No. 43 Report: A revised AAPM protocol for brachytherapy dose calculations, Medical physics, 31(3) (2004) 633-674. [7] J.I. Monroe, J.F. Williamson. Monte Carlo‐aided dosimetry of the Theragenics TheraSeed® Model 200 interstitial brachytherapy seed, Medical physics, 29(4) (2002) 609-621. [8] P. Taherparvar, A. Sadremomtaz. Development of GATE Monte Carlo simulation for a CsI pixelated gamma camera dedicated to high resolution animal SPECT, Australasian physical & engineering sciences in medicine, 41(4) (2018) 31-39. [9] P. Papadimitroulas, Using GATE for radiation therapy applications, Physica Medica, 32(3) (2016) 190-191. [10] H. Badry, L. Oufni, H. Ouabi, H. Hirayama. A Monte Carlo investigation of the dose distribution for 60Co high dose rate brachytherapy source in water and in different media, Applied Radiation and Isotopes, 136 (2018) 104-110. [11] M. Ghorbani, F. Salahshour, A. Haghparast, T.A. Moghaddas, C. Knaup. Effect of tissue composition on dose distribution in brachytherapy with various photon emitting sources, Journal of contemporary brachytherapy, 6(1) (2014) 54-67. [12] I.C.o.R. Units, Measurements. “Tissue substitutes in radiation dosimetry and measurement,” ICRU Report No. 44, (1989). [13] R. Taylor, G. Yegin, D. Rogers. Benchmarking brachydose: voxel based EGSnrc Monte Carlo calculations of TG‐43 dosimetry parameters, Medical physics, 34(2) (2007) 445-457. [14] J.F. Williamson. Monte Carlo modeling of the transverse‐axis dose distribution of the Model 200 interstitial brachytherapy source, Medical physics, 27(4) (2000) 643-654. [15] H. Rezaee, Z. Shakarami, M. Hosseini, M. Zabihzadeh, M. Feghhi. Dosimetric characteristics of 103 Pd (theragenices, model 200) brachytherapy source, Biomedical and Pharmacology Journal, 8 (2015) 15-23.